Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody
US11180549B2 · kind B2 · utility
0Cited by
37References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 17, 2019 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Dec 23, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.